National Center for Health Statistics: Health, United States, 2010; With Special Feature on Death and Dying. 2010, Hyattsville, MD
Google Scholar
Dudeck MA, Horan TC, Peterson KD, Allen-Bridson K, Morrell G, Pollock DA, Edwards JR: National Healthcare Safety Network (NHSN) report, data summary for 2010, device-associated module. Am J Infect Control. 2011, 39: 798-816. 10.1016/j.ajic.2011.10.001.
Article
PubMed
Google Scholar
Klevens RM, Edwards JR, Gaynes RP: National Nosocomial Infections Surveillance System. The impact of antimicrobial-resistant, healthcare-associated infections on mortality in the United States. Clin Infect Dis. 2008, 47: 927-930. 10.1086/591698.
Article
PubMed
Google Scholar
Jernigan JA: Overview of antimicrobial resistance -- antibacterial resistance. FDA Public Meeting: Antibacterial Resistance and Diagnostic Device and Drug Development Research for Bacterial Diseases. 2010, Public Workshop, Silver Spring, MD, 26-27 July,http://www.fda.gov/downloads/Drugs/NewsEvents/UCM226072.pdf,
Google Scholar
Campbell RJ, Giljahn L, Machesky A, Cibulskas-White K, Lane LM, Porter K, Paulson JO, Smith FW, McDonald LC: Clostridium difficile infection in Ohio hospitals and nursing homes during 2006. Infect Control Hosp Epidemiol. 2009, 30: 526-533. 10.1086/597507.
Article
PubMed
Google Scholar
Bartlett JG: A call to arms: the imperative for antimicrobial stewardship. Clin Infect Dis. 2011, 53 (Suppl 1): 4-7. 10.1093/cid/cir362.
Article
Google Scholar
Septimus EJ, Owens RC: Need and potential of antimicrobial stewardship in community hospitals. Clin Infect Dis. 2011, 53 (Suppl 1): 8-14. 10.1093/cid/cir363.
Article
Google Scholar
Ohl CA, Dodds Ashley ES: Antimicrobial stewardship programs in community hospitals: the evidence base and case studies. Clin Infect Dis. 2011, 53 (Suppl 1): 23-28. 10.1093/cid/cir365.
Article
Google Scholar
Dellit TH, Owens RC, McGowan JE, Gerding DN, Weinstein RA, Burke JP, Huskins WC, Paterson DL, Fishman NO, Carpenter CF, Brennan PJ, Billeter M, Hooton TM, Infectious Diseases Society of America, Society for Healthcare Epidemiology of America: Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007, 44: 159-177. 10.1086/510393.
Article
PubMed
Google Scholar
Barlam TF, DiVall M: Antibiotic-stewardship practices at top academic centers throughout the United States and at hospitals throughout Massachusetts. Infect Control Hosp Epidemiol. 2006, 27: 695-703. 10.1086/503346.
Article
PubMed
Google Scholar
Trivedi K, Rosenberg J: The state of antimicrobial stewardship programs in California. 2011, 21st Annual Scientific Meeting of the Society for Healthcare Epidemiology of America, Dallas, TX 1-4 April, [Abstract 376]-http://shea.confex.com/shea/2011/webprogram/Paper4907.html,
Google Scholar
Johannsson B, Beekman SE, Srinivasan A, Hersh AL, Laxminarayan R, Polgreen PM: Improving antimicrobial stewardship: the evolution of programmatic strategies and barriers. Infect Control Hosp Epidemiol. 2011, 32: 367-374. 10.1086/658946.
Article
PubMed
Google Scholar
Kuntz JL, Cavanaugh JE, Becker LK: Clostridium difficile-associated disease in patients in a small rural hospital. Infect Control Hosp Epidemiol. 2007, 28: 1236-1239. 10.1086/521662.
Article
PubMed
Google Scholar
LaRocco A: Concurrent antibiotic review programs – a role for infectious diseases specialists at small community hospitals. Clin Infect Dis. 2003, 37: 742-743. 10.1086/377286.
Article
PubMed
Google Scholar
National Healthcare Safety Network (NHSN): Multidrug-Resistant Organism & Clostridium difficile Infection (MDRO/CDI) Module Protocol.http://www.cdc.gov/nhsn/PDFs/pscManual/12pscMDRO_CDADcurrent.pdf,
Carling P, Fung T, Killion A, Terrin N, Barza M: Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect Control Hosp Epidemiol. 2003, 24: 699-706. 10.1086/502278.
Article
PubMed
Google Scholar
Ruttiman S, Keck B, Hartmeier C, Maetzel A, Bucher HC: Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital. Clin Infect Dis. 2004, 38: 348-356. 10.1086/380964.
Article
Google Scholar
Fraser GL, Stogsdill P, Dickens JD, Wennberg DE, Smith RP, Prato S: Antibiotic optimization. An evaluation of patient safety and economic outcomes. Arch Int Med. 1997, 157: 1689-1694. 10.1001/archinte.1997.00440360105012.
Article
CAS
Google Scholar
Filius PMG, Liem TB, van der Linden PD, Janknegt R, Natsch S, Vulto AG, Verbrugh HA: An additional measure for quantifying antibiotic use in hospitals. J Antimicrob Chemother. 2005, 55: 805-808. 10.1093/jac/dki093.
Article
CAS
PubMed
Google Scholar
Ansari F, Molana H, Goossens H, Davey P: Development of standardized methods for analysis of changes in antibacterial use in hospitals from 18 European countries: the European Surveillance of Antimicrobial Consumption (ESAC) longitudinal survey, 2000–06. J Antimicrob Chemother. 2010, 65: 2686-2691.
Google Scholar
Jacob JT, Gaynes RP: Emerging trends in antibiotic use in US hospitals: quality, quantification and stewardship. Expert Rev Anti Infect Ther. 2010, 8: 893-902. 10.1586/eri.10.73.
Article
PubMed
Google Scholar
Stevens V, Dumyati G, Fine LS, Fisher SG, van Winjgaarden E: Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection. Clin Infect Dis. 2011, 53: 42-48. 10.1093/cid/cir301.
Article
PubMed
Google Scholar
Werner NL, Hecker MT, Sethi AK, Donskey CJ: Unnecessary use of fluoroquinolone antibiotics in hospitalized patients. BMC Infect Dis. 2011, 11: 187-10.1186/1471-2334-11-187.
Article
PubMed Central
CAS
PubMed
Google Scholar
me: Centers for Medicaid and Medicare Services and The Joint Commission Specifications Manual for National Hospital Inpatient Quality Measures.http://www.jointcommision.org/specifications_manual_for_national_hospital_inpatient_quality_measures.aspx,
Pepin J, Saheb N, Coulombe MA, Alary ME, Corriveau MP, Authier S, Leblanc M, Rivard G, Bettez M, Primeau V, Nguyen M, Jacob CE, Lanthier L: Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis. 2005, 41: 1254-1260. 10.1086/496986.
Article
CAS
PubMed
Google Scholar
MacDougall C, Powell JP, Johnson CK, Edmond MB, Polk RE: Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals. Clin Infect Dis. 2005, 41: 435-440. 10.1086/432056.
Article
CAS
PubMed
Google Scholar
Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y: Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother. 2008, 52: 1028-1033. 10.1128/AAC.01020-07.
Article
PubMed Central
CAS
PubMed
Google Scholar
Fong KS, Fatica C, Hall G, Procop G, Schindler S, Gordon SM, Fraser TG: Impact of PCR testing for Clostridium difficile on incident rates and potential on public reporting: is the playing field level?. Infect Control Hosp Epidemiol. 2011, 32: 932-933. 10.1086/661789.
Article
PubMed
Google Scholar
Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pepin J, Wilcox MH, Society for Healthcare Epidemiology of America, Infectious Diseases Society of America: Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol. 2010, 31: 431-455. 10.1086/651706.
Article
PubMed
Google Scholar